Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2‑Grupa study

Bała, Małgorzata M; Płaczkiewicz-Jankowska, Ewa; Leśniak, Wiktoria; Michałejko, Magdalena; Jankowski, Miłosz; Strzeszyński, Lukasz; Sieradzki, Jacek; Czupryniak, Leszek

doi:10.20452/pamw.1964

Cited by 10 publications

(22 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The patient and physician characteristics and the results related to diabetes control was described elsewhere [10]. Sixty per cent of all patients had HbA1c level above 7.0%.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study

Leśniak

Bała

Płaczkiewicz-Jankowska

et al. 2015

Cardiol J

Self Cite

View full text Add to dashboard Cite

show abstract

“…The patient and physician characteristics and the results related to diabetes control was described elsewhere [10]. Sixty per cent of all patients had HbA1c level above 7.0%.…”

Section: Resultsmentioning

confidence: 99%

“…Detailed description of the ARETAEUS2--Grupa study design, protocol, questionnaire, inclusion criteria for the study, recruitment procedures of physicians and their patients and sample size calculations was published previously [8]. Briefly, ARETAEUS2-Grupa was a cross-sectional questionnaire-based study conducted in Poland (April-June 2012).…”

Section: Methodsmentioning

confidence: 99%

Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study

Leśniak

Bała

Płaczkiewicz-Jankowska

et al. 2015

Cardiol J

Self Cite

View full text Add to dashboard Cite

show abstract

“…Physicians and patients were recruited to those two arms separately. This paper on patients with T2DM lasting > 10 years concerns only patients participating in ARATAEUS2-Grupa Study; the results for patients with T2DM of short duration have been reported elsewhere [9].…”

Section: Methodsmentioning

confidence: 99%

“…Patient inclusion criteria for the study ARETAEUS2-Grupa Study included two groups of patients of any age and both genders: -those diagnosed with type 2 diabetes within the previous two years (after 1 April, 2010) [9] who met the same inclusion criteria as in the ARETAEUS1 Study [2]; -those diagnosed with type 2 diabetes more than ten years before the study commencement (before 2002), in order to obtain data on treatment and disease control in intermediate to long-lasting diabetes.…”

Section: Methodsmentioning

confidence: 99%

“…Milder criteria (HbA1c ≤ 8%) are recommended for patients over 70 with long lasting T2DM, with a history of myocardial infarction or stroke [7,8]. In the ARETAEUS2-Grupa study, we aimed to describe the characteristics of the T2DM population in Poland, including examining and diagnosing late diabetes complications, and examine diabetes control and treatment used both in patients with T2DM of short duration [9] and those with T2DM of more than ten years' duration presented here.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Leczenie i spełnianie celów leczenia u polskich chorych na cukrzycę typu 2 od ponad 10 lat — wyniki badania ARETAEUS2-Grupa

Bała

Płaczkiewicz-Jankowska²,

Leśniak

et al. 2014

Endokrynologia Polska

Self Cite

View full text Add to dashboard Cite

Introduction: Previous studies have shown insufficient diabetes control in patients with type 2 diabetes (T2DM). Diabetes Poland changed the target HbA1c and blood pressure (BP) values in diabetic patients in their practice guidelines in 2011, that were further sustained. To assess the management and treatment choices in T2DM of more than ten years' duration and the degree to which diabetic control criteria recommended by the Diabetes Poland clinical practice guidelines 2012 are being met. Material and methods: ARETAEUS2-Grupa was a cross-sectional questionnaire-based study conducted in Poland in 2012 (April-June). It involved 1,740 patients of any age and both genders, with T2DM diagnosed more than ten years before the study, and recruited by randomly selected physicians. Results: All patients received pharmacological treatment, most of them combination therapy or insulin in monotherapy. 40% of patients met the goal for HbA1c control (≤ 7%) and the median value of HbA1c was above the recommended threshold (7.2%). Only 8% of the total population met all three goals (HbA1c, BP and lipid levels), 26% -two goals, and 40% -only one goal. Over 25% of patients did not meet any of the treatment goals. Conclusions: We observed considerable deviations from treatment targets recommended by current clinical practice guidelines for patients with T2DM of more than ten years' duration. The frequency of cardiovascular risk factors and late diabetes complications was high, while a relatively high percentage of patients was not examined for late diabetes complications. (Endokrynol Pol 2014; 65 (3): 158-168)

show abstract

Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis

Khunti

Ceriello²,

Cos

et al. 2018

Diabetes Research and Clinical Practice

137

100

View full text Add to dashboard Cite

We assessed global achievement of targets recommended by the American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD), and National Institute of Health and Care Excellence (NICE) for type 2 diabetes. We searched Medline, Embase, and The Cochrane Library for observational studies reporting target attainment (2006 to 2017 inclusive) for HbA1c, blood pressure, or lipids (low density lipoprotein cholesterol [LDL-C], high density lipoprotein cholesterol [HDL-C], or triglycerides). Rates were pooled using a random-effects meta-analysis. Study quality and risk of small study of bias was assessed. From 2491 screened records, 24 studies were included reporting on 369,251 people from 20 countries. The pooled target achievement rates were; 42.8% (95% CI 38.1-47.5%) for glycaemic control, 29.0% (22.9-35.9%) for blood pressure, 49.2% (39.0-59.4%) for LDL-C, 58.2% (51.7-64.4%) for HDL-C, and 61.9% (55.2-68.2%) for triglyceride control. A higher proportion of people achieved HbA1c targets within Europe and North America than the rest of the world. A higher proportion of people achieved blood pressure targets in North America than Europe or the rest of the world. Meta regression showed no significant improvement in rates by year for any target. The achievement of evidence-based targets is markedly suboptimal globally and not improving.

show abstract

Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2‑Grupa study

Cited by 10 publications

References 0 publications

Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study

Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study

Leczenie i spełnianie celów leczenia u polskich chorych na cukrzycę typu 2 od ponad 10 lat — wyniki badania ARETAEUS2-Grupa

Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis

Contact Info

Product

Resources

About